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transient ST elevation was present in 24% of patients. Clinical
outcome at long term follow-up was better as compared to patients
without T-STE. An early invasive strategy in patients with T-STE ACS
was feasible but not superior to a late invasive strategy in terms of the
combined primary endpoint of death, reinfarction and/or recurrent
ischemia. Infarct size was comparable. Postponement of intervention
for prolonged pharmacological pretreatment did not result in
improved outcome. Prospective, randomized trials are necessary for
more evidence in the optimal treatment of these patients. ISRCTN
register 39230163
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BACKGROUND The Thrombus Aspiration in ST-Elevation myocardial
infarction in Scandinavia (TASTE) trial did not demonstrate clinical
beneﬁt of thrombus aspiration (TA). High risk patients might beneﬁt
from TA.
METHODS The TASTE trial was a multicenter, randomized,
controlled, open-label trial obtaining endpoints from national regis-
tries. Patients (n¼7244) with ST segment elevation myocardial
infarction (STEMI) undergoing percutaneous coronary intervention
(PCI) were randomly assigned 1:1 to TA and PCI or to PCI alone. We
assessed the one-year clinical effect of TA in a sub-group with
potentially large anterior STEMI: mid or proximal left anterior
descending coronary artery infarct lesion, TIMI 0-2 ﬂow, and symp-
tom-onset-to-PCI time 5 h. In this sub-study, patient eligibility
criteria corresponded to that of the Intracoronary Abciximab and
Aspiration Thrombectomy in Patients with Large Anterior Myocardial
Infarction (INFUSE-AMI) study.
RESULTS In total, 1826 patients fulﬁlled inclusion criteria. All-cause
mortality at one year of patients randomized to TA did not differ from
those randomized to PCI only [hazard ratio (HR) 1.05, 95% conﬁdence
interval (CI) 0.74-1.49, P¼0.77]. Rates of rehospitalization for
myocardial infarction (MI), heart failure (HF), and stent thrombosis
(ST) did not differ between groups (HR 0.87, 95% CI 0.51-1.46, P¼0.59;
HR 1.10 95% CI 0.77-1.58, P¼0.58; and HR 0.75, 95% CI 0.30-1.86,
P¼0.53; respectively). This was also the case for the combined
endpoint of all-cause mortality, and rehospitalization for MI, HF, or ST
(HR 1.00, 95% CI 0.79-1.26, P¼0.99).CONCLUSIONS In patients with STEMI and large area of myocardium
at risk, TA did not affect outcome within one year.
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BACKGROUND Spontaneous coronary artery dissection (SCAD) is an
infrequent but important cause of myocardial infarction (MI) in
women. Chronic exposure to hormonal therapy, ﬂuctuation in hor-
monal levels, and a history of multiple pregnancies had been postu-
lated to predispose to SCAD. However, these were not well described
in the literature.
METHODS Women with SCAD who have consented and are prospec-
tively followed in our Vancouver General Hospital SCAD registries are
included in this study. Their background hormonal exposure, preg-
nancy, and gynecological histories were extracted from question-
naires, clinical histories, and medical records. These were correlated
to in-hospital and long-term outcomes.
RESULTS We included 187 women with SCAD, with mean age 52.6 
8.7 years. The majority were Caucasian (83.4%) and 74.0% had
ﬁbromuscular dysplasia. All patients presented with MI. Mean num-
ber of pregnancy in this cohort was 2.5, with 45 (24.1%) and 25 (13.4%)
having 4 and 5 pregnancies, respectively. Mean number of live
births (parity) was 1.8, with 52 (27.8%) having 3 births, and 16 (8.6%)
having 4 births. There were 3 post-partum SCAD (<1 year) and they
were still breastfeeding. In terms of hormonal therapy, 28 (15.0%)
were actively on hormonal therapy; 5 (2.7%) had prior fertility treat-
ment, 51 (27.3%) had hormone replacement therapy (HRT), 76 (40.6%)
had oral contraception, and 36 (19.3%) had gynecological procedures.
There were 107 (57.2%) post-menopausal women, and 23 (12.3%) were
peri-menopausal at presentation. There was no death during acute
SCAD admission, but 3 died at follow-up (mean 4.1  3.9 years), and 36
(19.3%) had recurrent SCAD. Patients actively on hormones had higher
rate of recurrent SCAD (32.1% vs. 15.8%, p¼0.039). There was a higher
recurrent MI rate in premenopausal women during index admission
(8.9% vs. 1.9%, p¼0.037). There was no signiﬁcant difference in in-
hospital and follow-up events in women with past hormonal therapy,
post-partum women, or those with parity 4 or gravida 5.
CONCLUSIONS Signiﬁcant proportion of women with SCAD had
exposure to hormonal therapy or had multiple pregnancies/births.
Patients actively on hormonal therapy appeared to have higher
recurrent SCAD events at follow-up.
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BACKGROUND Percutaneous closure of ventricular septal rupture
(VSR) complicating acute myocardial infarction appears to be safe and
effective treatment, but there is no uniﬁed opinion about the inter-
vention timing for transcatheter closure due to the lack of large-scale
prospective clinical research.
METHODS Between October 2010 and April 2013, 43 consecutive ST-
elevation myocardial infarction (STEMI) complicating VSR patients
who had indications of primary transcatheter closure were enrolled in
our study. We excluded cardiogenic shock patients. These patients
were randomly assigned to either the early intervention group (n¼21)
or the late intervention group (n¼22). We applied percutaneous
closure of VSR within 2 weeks after STEMI for patients in early
intervention group, while we applied percutaneous closure of VSR in
6 weeks after STEMI for patients in late intervention group. We
recorded the procedure-related complications and followed up these
patients for 2 years.
